Sign In
Get Clay Free →

Suggestions

    Matthew Durdy

    Matthew Durdy is a distinguished professional with a diverse background encompassing biology, investment, and entrepreneurship.

    Currently serving as the Chief Executive Officer of the Cell and Gene Therapy Catapult, Matthew is instrumental in the development of business strategies for the organization.

    With a solid foundation in US investment banking, Matthew progressed to overseeing new investment due diligence at a global private equity and investment firm.

    His expertise extends to new venture strategy, innovation management, and biotechnology leadership, highlighting his versatility across multiple domains.

    Matthew's career pivoted successfully back to biology with his impactful role in the turnaround of Biotec Laboratories, demonstrating his acumen in managing change and driving profitability.

    As the founder of consultancy firm Aught, Matthew imparts his knowledge by teaching new venture strategy at the University of Chicago Booth School of Business.

    In addition, he has provided expert advisory services on innovation investment to prestigious organizations such as the World Health Organization, Gates Foundation, and the UK Technology Strategy Board.

    Matthew Durdy's academic credentials include a BA (Hons.) in Natural Science from Christ Church, Oxford, and an MBA with High Honors from the University of Chicago, Booth School of Business.

    Apart from his professional commitments, Matthew also serves as the Vice-Chair of the esteemed medical charity Parkinson's UK.

    To learn more about Matthew Durdy, visit www.durdy.com or connect with him on Twitter via @MatthewDurdy.

    Matthew Durdy
    Add to my network

    Location

    London, England, United Kingdom